Hormone therapy can change what your mammogram looks like, and almost nobody is told this before their first scan on treatment. The result is a recall letter that causes real fear, or a "dense breast tissue" note on a report with no explanation of what it means. Here is what is actually going on.
Where we stand: Menova is an independent publication. We sell no hormones and no screening, we are not your doctor, and this is general education, not medical advice. Screening programmes differ by country — confirm your own schedule locally.
Keep going to screening
The first and most important point: being on hormone therapy is a reason to attend screening, not to avoid it. Whatever else is true here, the woman who stops attending is worse off.
What HRT does to the image
Combined estrogen-plus-progestogen therapy can increase mammographic breast density in some women, typically within the first year. Estrogen-only therapy has less effect.
Density matters for two practical reasons:
- Dense tissue appears white on a mammogram — and so do most abnormalities. More white tissue means less contrast, and slightly lower sensitivity
- Higher density is itself associated with somewhat higher breast cancer risk, independent of hormone therapy
The consequence women actually experience: a higher chance of being recalled for additional views, particularly on the first scan after starting treatment. Most recalls turn out to be nothing.
About "dense breasts" on your report
Density is reported in categories, and it is common — a large proportion of women in their forties and fifties have dense breasts. It is not a disease and not an abnormal finding.
What it may change:
- Some countries and states now require that you are notified
- Supplementary imaging — ultrasound, or MRI for higher-risk women — is offered or discussed in some settings
- Tomosynthesis (3D mammography) performs better than standard mammography in dense tissue and is standard in many centres
Density also tends to decrease with age and after menopause — one reason it may be noted more in perimenopause than later.
Worth asking: "What is my density category, does my programme offer supplementary imaging for it, and does it change what I should do?"
Tell them you are on hormone therapy
Say it at booking and again at the appointment, including:
- The exact product and whether it is estrogen-only or combined
- How long you have been on it
- Any vaginal estrogen, which women routinely forget — even though absorption is minimal, it belongs on the record
- Any change of dose or product since your last scan
Context reduces unnecessary recalls, because a radiologist comparing this year's image with last year's benefits from knowing what changed in between.
About the risk question
This is a separate matter from imaging, and it deserves plain numbers rather than either reassurance or alarm.
Combined estrogen-plus-progestogen therapy is associated with a small increase in breast cancer risk, which rises with duration of use and declines after stopping. Estrogen-only therapy — used by women without a uterus — has shown little or no increase in the major studies, and in some analyses a reduction.
For context, several familiar factors carry comparable or larger associations: regular alcohol intake, being overweight after menopause, and physical inactivity.
We treat the numbers properly in HRT and breast cancer risk in numbers and the broader balance in HRT risks and benefits. The point here is that "HRT changes my mammogram" and "HRT changes my risk" are two different conversations, and conflating them causes unnecessary fear.
If you are recalled
Recall is common and usually resolves with no further action. What typically happens:
- Additional mammogram views, sometimes magnified or compressed differently
- An ultrasound
- Occasionally a biopsy, which is usually a needle procedure under local anaesthetic
Practical notes: take someone with you if it helps, ask when results will come and by what route, and ask directly what they are looking at. Vague reassurance is harder to sit with than a specific explanation.
If you are called back after your first scan on hormone therapy, mention that you recently started it.
Breast changes on HRT that are expected
- Tenderness and fullness in the first weeks to months, often settling — see your first three months on HRT
- Cyclical tenderness, particularly with cyclical progestogen
- A change in size or fit
Persistent tenderness is worth raising, since dose or progestogen type can often be adjusted — see breast pain and changes in menopause.
What is never "just the HRT"
Get these checked promptly, regardless of what you take:
- A new lump in the breast or armpit
- A change in size or shape of one breast
- Skin dimpling, puckering, or an orange-peel texture
- Nipple inversion that is new, or a rash on the nipple
- Any nipple discharge, particularly blood-stained or from one duct
- Persistent pain in one specific spot that does not vary with your cycle
Never wait for a scheduled mammogram with any of these — a normal recent scan does not rule out a new lump.
If you have a family history
Say so explicitly, including relatives' ages at diagnosis and any known gene variants. It may change your screening schedule, your eligibility for MRI, and the hormone therapy conversation — see family history and menopause.
If you have had breast cancer yourself, hormone therapy is a specialist conversation with different considerations, and effective non-hormonal options exist — see menopause after breast cancer and non-hormonal prescription options.
Practical points for the appointment itself
- Book for after your period if you are still cycling — breasts are less tender
- No deodorant, talc or lotion on the day, as particles can appear on the image
- Bring the name of your hormone product, or a photo of the box
- Ask for your density category if it is not stated
Our free printable visit prep sheet gives you a page for your product list and questions, and health screening in your 50s covers what else belongs in this decade.
The free 2-minute Menova self-check organizes your symptom picture — no account, not a diagnosis, and your answers never leave your device.
This article is general education, not medical advice. Screening programmes, density reporting and supplementary imaging differ by country and by individual risk. Report any new breast lump or skin or nipple change to a licensed clinician promptly, without waiting for scheduled screening.
Sources: National Cancer Institute — Understanding Breast Changes, ACOG — Mammography and Breast Screening, The Menopause Society, and NHS — Breast Screening.